246 related articles for article (PubMed ID: 22912357)
41. Emerging drugs for alpha-1-antitrypsin deficiency.
Stockley RA
Expert Opin Emerg Drugs; 2010 Dec; 15(4):685-94. PubMed ID: 20716026
[TBL] [Abstract][Full Text] [Related]
42. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?
Schmechel DE
Neurotoxicology; 2007 Sep; 28(5):899-914. PubMed ID: 17659342
[TBL] [Abstract][Full Text] [Related]
43. Facilitating the laboratory diagnosis of α1-antitrypsin deficiency.
Greene DN; Elliott-Jelf MC; Straseski JA; Grenache DG
Am J Clin Pathol; 2013 Feb; 139(2):184-91. PubMed ID: 23355203
[TBL] [Abstract][Full Text] [Related]
44. [Genetic risk factor AAT deficiency. Also heterozygotes carry the risk of pulmonary emphysema].
MMW Fortschr Med; 2006 May; 148(21):57. PubMed ID: 16796193
[No Abstract] [Full Text] [Related]
45. Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens.
Rodriguez F; Jardí R; Costa X; Cotrina M; Galimany R; Vidal R; Miravitlles M
Am J Respir Crit Care Med; 2002 Sep; 166(6):814-7. PubMed ID: 12231490
[TBL] [Abstract][Full Text] [Related]
46. Is the diagnostic rate for the common subtypes of A1AT deficiency consistent across two Canadian Provinces?
Estey MP; Tahooni T; Nelson TN; Parker ML; Agbor TA; Yang HM; Jen R; Barakauskas VE; Lam GY; Matthews A; Mattman A
Clin Biochem; 2021 Sep; 95():84-88. PubMed ID: 33964271
[TBL] [Abstract][Full Text] [Related]
47. Alpha-1-antitrypsin phenotypes in patients with ankylosing spondylitis.
Sierakowski S; Chwiećko J; Kita K
Rocz Akad Med Bialymst; 2001; 46():54-9. PubMed ID: 11780580
[TBL] [Abstract][Full Text] [Related]
48. [Study of the frequency of different phenotypes of alpha-1-antitrypsin in a population of Barcelona].
Vidal R; Miravitlles M; Jardí R; Torrella M; Rodríguez-Frías F; Moral P; Vaqué J
Med Clin (Barc); 1996 Jul; 107(6):211-4. PubMed ID: 8755448
[TBL] [Abstract][Full Text] [Related]
49. Analysis of the alpha-1-antitrypsin deficient alleles M3S, MZ, and ZZ by biochemical and molecular methods: a family study.
Calapoğlu M; Değer O; Balaban F; Sahin Calapoğlu N; Bülbül Y; Burling K
Biochem Genet; 2009 Feb; 47(1-2):33-41. PubMed ID: 19083091
[TBL] [Abstract][Full Text] [Related]
50. Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin.
Laffranchi M; Elliston EL; Miranda E; Perez J; Ronzoni R; Jagger AM; Heyer-Chauhan N; Brantly ML; Fra A; Lomas DA; Irving JA
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699193
[TBL] [Abstract][Full Text] [Related]
51. Advances in alpha-1-antitrypsin deficiency liver disease.
Teckman JH; Jain A
Curr Gastroenterol Rep; 2014 Jan; 16(1):367. PubMed ID: 24338605
[TBL] [Abstract][Full Text] [Related]
52. Alpha-1-antitrypsin associated panniculitis: the MS variant.
Geraminejad P; DeBloom JR; Walling HW; Sontheimer RD; VanBeek M
J Am Acad Dermatol; 2004 Oct; 51(4):645-55. PubMed ID: 15389208
[TBL] [Abstract][Full Text] [Related]
53. Results of a case-detection programme for alpha1-antitrypsin deficiency in COPD patients.
de la Roza C; Rodríguez-Frías F; Lara B; Vidal R; Jardí R; Miravitlles M
Eur Respir J; 2005 Oct; 26(4):616-22. PubMed ID: 16204591
[TBL] [Abstract][Full Text] [Related]
54. Alpha-1-antitrypsin deficiency: current concepts.
Mulgrew AT; Taggart CC; McElvaney NG
Lung; 2007; 185(4):191-201. PubMed ID: 17562108
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of a new Sebia isoelectrofocusing kit for alpha 1-antitrypsin phenotyping with the Hydrasys System.
Zerimech F; Hennache G; Bellon F; Barouh G; Jacques Lafitte J; Porchet N; Balduyck M
Clin Chem Lab Med; 2008; 46(2):260-3. PubMed ID: 18076352
[TBL] [Abstract][Full Text] [Related]
56. Alpha 1-antitrypsin activity is markedly decreased in Wegener's granulomatosis.
Mota A; Sahebghadam Lotfi A; Jamshidi AR; Najavand S
Rheumatol Int; 2014 Apr; 34(4):553-8. PubMed ID: 23604680
[TBL] [Abstract][Full Text] [Related]
57. Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology.
Ottaviani S; Barzon V; Buxens A; Gorrini M; Larruskain A; El Hamss R; Balderacchi AM; Corsico AG; Ferrarotti I
J Clin Lab Anal; 2020 Jul; 34(7):e23279. PubMed ID: 32181528
[TBL] [Abstract][Full Text] [Related]
58. Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis.
Clemmensen SN; Jacobsen LC; Rørvig S; Askaa B; Christenson K; Iversen M; Jørgensen MH; Larsen MT; van Deurs B; Ostergaard O; Heegaard NH; Cowland JB; Borregaard N
Eur J Haematol; 2011 Jun; 86(6):517-30. PubMed ID: 21477074
[TBL] [Abstract][Full Text] [Related]
59. The prevalence of alpha(1)-antitrypsin deficiency in a representative population sample from Poland.
Kaczor MP; Sanak M; Libura-Twardowska M; Szczeklik A
Respir Med; 2007 Dec; 101(12):2520-5. PubMed ID: 17693072
[TBL] [Abstract][Full Text] [Related]
60. [Molecular diagnostics of alpha-1-antitrypsin deficiency in clinical practice].
Struniawski R; Szpechciński A; Chorostowska-Wynimko J
Pneumonol Alergol Pol; 2008; 76(4):253-64. PubMed ID: 18785130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
